At 12-month follow-up , the median % VP in SND patients was 0.20 % in the MVP group and 1.4 % in the SAV + group ( P < 0.0001 ) and the median % VP in AVB patients was 11.8 % in the MVP group and 98.1 % in the SAV + group ( P < 0.001 ) .